ESR1 and breast carcinoma: Since most published studies focus on targeting breast cancer cell lines in general, irrespective of their receptor expression status, the present study was undertaken to identify key biological processes and novel molecular target genes affected by WA in triple negative metastatic breast cancer cells (MDA-MB-231) as compared to non-invasive ER-positive MCF-7 cells.